Pediatric Research

Research in pediatrics is focused on psychiatric, developmental, cognitive, and educational projects that help children reach their genetic potential. Research is aimed at better understanding of the conditions through diagnostic sub-grouping and individuation, as well as appropriately targeted treatments ranging from CAM modalities to educational programs. Herscu laboratory has a particular interest in the pediatric population diagnosed with ADD/ADHD, Autism Spectrum Disorders, and Bipolar Disorders.


Herscu Laboratory is researching current diagnostic categorization, the success and targeting of available drugs, and the potential development of novel compounds in ADHD. With all aspects, the focus is on developing tools to individualize treatment options by redefining clinically-relevant sub-populations within larger diagnostic or treatment categories.

ADHD Drug Development

Herscu Laboratory is partnering with Whewell Biosciences to produce a novel drug treatment for ADHD. The molecule is currently being researched in animal testing phase at Central Michigan University.

ADHD Treatment Targeting Enhancement

Herscu Laboratory and PPS are continuing research into ADHD sub-typing and prediction of individual treatment response for specific pharmaceuticals.

Autistic Spectrum Disorders (ASD)

Herscu Laboratory is developing tools to help sub-categorize ASD children into refined clinical categorizations that are relevant to treatment decisions. Accurate sub-diagnoses will be compared to success and failure of available interventions in order to increase the accuracy of clinical treatment and reduce side effects.

ASD Drug Development


Herscu Laboratory is partnering with Whewell Biosciences in the development of a novel compound for ASD treatment. The molecule is currently in the initial stages of research and development.

Epilepsy in children

Herscu Laboratory is developing tools to better diagnose and sub-categorize children suffering from epilepsy in order to advance the ability to individualize, and thus enhance the efficacy of, pharmaceutical and other treatment. As in the ADHD research, the primary goals are better differentiation of medically-relevant sub-groups of epilepsy sufferers, better understanding of individual differences in pathomechanism, and well-tailored application of treatment.


See all pediatrics related publications here